Paper41206007
HMGCR and Rosuvastatin Regulates GLP-1 Secretion and Expression-A Translational Study.
Miskelly MG and 19 others. J Clin Endocrinol Metab, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. HMGCR and Rosuvastatin Regulates GLP-1 Secretion and Expression-A Translational Study. Papers, record 41206007. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41206007
- Cell line
- GLUTag7 papers
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Cell lines1
Source Cell lines
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Rosuvastatin Calcium | Major topic |
| Glucagon-Like Peptide 1 | Major topic |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | Major topic |
| Diabetes Mellitus, Type 2 | Major topic |
| Hydroxymethylglutaryl CoA Reductases | Major topic |
| Animals | |
| Mice | |
| Humans | |
| Female | |
| Male | |
| Middle Aged | |
| Mice, Inbred C57BL | |
| Translational Research, Biomedical | |
| Aged | |
| Cohort Studies | |
| Blood Glucose | |
| Hyperglycemia |
Source PubMed
Grants26
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2024-03413 | Swedish Research Council | PubMed | ||
| 2020-01017 | Swedish Research Council | PubMed | ||
| 2017-00862 | Swedish Research Council | PubMed | ||
| 349-2006-237 | Swedish Research Council | PubMed | ||
| 2020-02179 | Swedish Research Council | PubMed | ||
| 2022-00973 | Swedish Research Council | PubMed | ||
| 2019-01406 | Swedish Research Council | PubMed | ||
| 2018-02837 | Swedish Research Council | PubMed | ||
| Diabetes Wellness Research Foundation Sweden | PubMed | |||
| Albert Påhlsson Foundation | PubMed | |||
| Royal Physiographic Society in Lund | PubMed | |||
| DIA2022-723 | Swedish Diabetes Foundation | PubMed | ||
| Lund University Diabetes Centre | PubMed | |||
| IRC15-0067 | Swedish Foundation for Strategic Research | PubMed | ||
| grants from the Medical Faculty of Lund University Skane University Hospital | PubMed | |||
| Region Skåne | PubMed | |||
| 2021-0354 | Region Skåne and the Swedish Heart and Lung foundation | PubMed | ||
| 2019-0470 | Region Skåne and the Swedish Heart and Lung foundation | PubMed | ||
| Wallenberg Center for Molecular Medicine | PubMed | |||
| European Union's Research | PubMed |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27453321 | Dual Effect of Rosuvastatin on Glucose Homeostasis Through Improved Insulin Sensitivity and Reduced Insulin Secretion. | EBioMedicine | 2016 | https://conductscience.org/library/papers/27453321 | PubMed |
| 2 | 30367179 | Inhibiting PCSK9 - biology beyond LDL control. | Nat Rev Endocrinol | 2018 | https://conductscience.org/library/papers/30367179 | PubMed |
| 3 | 29627317 | Intestinal CART is a regulator of GIP and GLP-1 secretion and expression. | Mol Cell Endocrinol | 2018 | https://conductscience.org/library/papers/29627317 | PubMed |
| 4 | 20167359 | Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. | Lancet | 2010 | https://conductscience.org/library/papers/20167359 | PubMed |
| 5 | 27312411 | MultiQC: summarize analysis results for multiple tools and samples in a single report. | Bioinformatics | 2016 | https://conductscience.org/library/papers/27312411 | PubMed |
| 6 | 17643200 | Cyclic AMP triggers glucagon-like peptide-1 secretion from the GLUTag enteroendocrine cell line. | Diabetologia | 2007 | https://conductscience.org/library/papers/17643200 | PubMed |
| 7 | 3514343 | Reduced incretin effect in type 2 (non-insulin-dependent) diabetes. | Diabetologia | 1986 | https://conductscience.org/library/papers/3514343 | PubMed |
| 8 | 24969582 | Statins and the risk of diabetes: evidence from a large population-based cohort study. | Diabetes Care | 2014 | https://conductscience.org/library/papers/24969582 | PubMed |
| 9 | 28887204 | Structural determinants in ApoA-I amyloidogenic variants explain improved cholesterol metabolism despite low HDL levels. | Biochim Biophys Acta Mol Basis Dis | 2017 | https://conductscience.org/library/papers/28887204 | PubMed |
| 10 | 38032369 | RNA sequencing unravels novel L cell constituents and mechanisms of GLP-1 secretion in human gastric bypass-operated intestine. | Diabetologia | 2024 | https://conductscience.org/library/papers/38032369 | PubMed |
| 11 | 21593115 | Incretin hormone and insulin responses to oral versus intravenous lipid administration in humans. | J Clin Endocrinol Metab | 2011 | https://conductscience.org/library/papers/21593115 | PubMed |
| 12 | 27959767 | Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes. | N Engl J Med | 2016 | https://conductscience.org/library/papers/27959767 | PubMed |
| 13 | 25516281 | Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. | Genome Biol | 2014 | https://conductscience.org/library/papers/25516281 | PubMed |
| 14 | 18997196 | Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. | N Engl J Med | 2008 | https://conductscience.org/library/papers/18997196 | PubMed |
| 15 | 22231607 | Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative. | Arch Intern Med | 2012 | https://conductscience.org/library/papers/22231607 | PubMed |
| 16 | 18806218 | Insulin secretion is highly sensitive to desorption of plasma membrane cholesterol. | FASEB J | 2009 | https://conductscience.org/library/papers/18806218 | PubMed |
| 17 | 25262344 | HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials. | Lancet | 2015 | https://conductscience.org/library/papers/25262344 | PubMed |
| 18 | 25746169 | Risk factors for the progression of carotid intima-media thickness over a 16-year follow-up period: the Malmö Diet and Cancer Study. | Atherosclerosis | 2015 | https://conductscience.org/library/papers/25746169 | PubMed |
| 19 | 8429286 | The Malmo Diet and Cancer Study. Design and feasibility. | J Intern Med | 1993 | https://conductscience.org/library/papers/8429286 | PubMed |
| 20 | 24464306 | Statin treatment, new-onset diabetes, and other adverse effects: a systematic review. | Curr Cardiol Rep | 2014 | https://conductscience.org/library/papers/24464306 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41206007
GET https://conductscience.org/api/papers/v1/41206007/grants?page=2